Early vascular alteration, atherosclerosis and coronary artery disease have emerged as important cardiovascular complications among beta-thalassemia major (B-TM) patients. The aims of the current study were to assess the prevalence of premature atherosclerosis among our B-TM patients, and to investigate the diagnostic value of serum Osteoprotegerin assay as an early biomarker for atherosclerosis.
This cross-sectional study was conducted at Hematology unit - Pediatric Department, Zagazig University Children Hospital- Egypt in the period from March 2014 to March 2015. A total of 115 children were enrolled in the current study; as sixty-five (65) children with beta thalassemia major aged 5–18 years, on regular blood transfusion regimen represented the patient group. While fifty (50) healthy children, with comparable age and gender, were assigned as control group. All participants were subjected to history taking, thorough clinical examination and laboratory investigations including; complete blood count, liver and kidney function tests, C- reactive protein, lipid profile, serum ferritin and serum Osteoprotegerin (OPG) assay. Also, carotid artery intima media thickness (CAIMT) was performed by duplex ultrasound for patients and controls.
Our B-TM patients were transfusion-dependent for as long as 8.5 ± 3.8 years with significantly higher serum ferritin levels (2490 ± 1579 ng/dl vs 83 ± 32 ng/dl, p = 0.001), C-reactive protein (5.7 ± 5.7 vs 0.9 ± 0.9), liver enzymes and bilirubin when compared to controls. Significantly higher serum triglyceride (128 ± 20 vs 101 ± 7 mg/dL, p = 0.009) and atherogenic index of plasma (0.45 ± 0.12 vs 0.22 ± 0.04, p = 0.001) were recorded in patients than comparisons. On the contrary, total serum cholesterol (116 ± 16 vs 143 ± 5, p < 0.001), low density lipoprotein-cholesterol (LDL-C) (44 ± 9 vs 73 ± 6, p < 0.001) and high density lipoprotein cholesterol (HDL-C) (39 ± 2 vs 61 ± 5, p < 0.001), were significantly lowered in patients versus normal peers. Carotid arteries intima media thickness (CAIMT) of both side were significantly increased for patients (Rt 0.62 ± 0.2 vs. 0.29 ± 0.07 mm, p = 0.001 & Lt 0.66 ± 0.17 vs 0.29 ± 0.05 mm, p = 0.001) when compared with healthy controls, and showed positive correlation with, serum triglyceride, atherogenic index of plasma, and serum Osteoprotegerin levels. ELISA assay of serum Osteoprotegerin (OPG) revealed significantly higher levels for thalassemia patients than matched healthy controls (427 ± 102 vs. 324 ± 126 pg/ml, p = 0.02). Of particular interest is the obvious positive correlation between OPG levels and CAIMT of both sides (Rt r 0.54, p = 0.001 &Lt r 0.479, p = 0.001) and also with serum triglycerides (r 0.374, p = 0.03).
Subclinical atherosclerosis started prematurely in children with beta- thalassemia. Carotid artery intima media thickness represented a simple, accurate and non-invasivemodality for early detection ofatherosclerosis. It was correlated well with serum Osteoprotegerin; this finding highlighted the possible validity of OPG assay as an early predictor of atherosclerosis in thalassemia children.
Muncie Jr HL, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80:339–44. PubMed
Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in thalassemia patients. Eur J ClinInv. 2002;32 suppl 1:55–60. CrossRef
Loizou CP, Pattichis CS, Nicolaides AN, Pantziaris M. Manual and automated media and intima thickness measurements of the common carotid artery. IEEE Trans UltrasonFerroelectrFreq Control. 2009;56:983–94. CrossRef
Min H, Morony S, Sarosi I, et al. Osteoprotegerin reverses osteoporosisby inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J ExpMed. 2000;192:463–74. CrossRef
Borgna-Pignatti C, Galanello R. Wintrobe's clinical hematology. 11. Vol. 42. Thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. Philadelphia: Lippincott Williams & Wilkins; 2004. pp. 1319–65.
Friedewald W, Levy RI, Freidrickson DS. Estimation of concentration of low-density lipoprotein in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;18:499–502. PubMed
Gursel O, Kureli AE, Tascilar E, et al. Premature atherosclerosis in children with B thalassemia major. J PediatrHematoloncol. 2012;34(8):630–4.
Fin AV, Kolodgie VR. Correlation between carotid intima-media thickness and atherosclerosis: a point of view from pathology. AtherisclerThromVascBiol. 2010;30:177–81.
Jarvisalo MJ, L. Jartti, K. Nanto-Salonen, K. Irjala, T. Ronnemaa, J. J. Hartiala, D. S. Celermajer, O. T. Raitakari, M. J. Jarvisalo, L. Jartti, K. Nanto-Salonen, K. Irjala, T. Ronnemaa, J. J. Hartiala, D. S. Celermajer, O. T. Raitakari (2001). Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 104 (24):2943–2947. CrossRefPubMed
Cheung TF, Chow PC, Chan GC, et al. Carotid intima media thickness is increased and related to arterial stiffness in patients with beta thalassemia major. Br J Hematol. 2006;135:732–4. CrossRef
Morris CR, Kuypers FA, Gregory J, Kato GJ, et al. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y AcadSci. 2005;1054:481–5. CrossRef
Morris CR, Kim HY, Klings ES, Wood J, et al. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassemia. Br J Hematol. 2015;169(6):887–98. CrossRef
Ragab SM, Safan MA, Sherif AS. Lipid profile in beta thalassemia children. Menofia Medical J. 2014;27:66–72. CrossRef
Vladislav S, Rapnael H, Caina L. Renal function in children with B-thalassemia major and thalassemia intermedia. PediatrNephrol. 2008;23:1847–51.
Livrea MA, Tesorere L, Maggio A, et al. Oxidative modification of low-density lipoprotein and atherogenic risk in B-thalassemia. Blood. 1998;92(10):3936–42. PubMed
Anca V, Arica S, Ozer C, et al. Serum lipid values in children with beta thalassemia major. PediatTherapeut. 2010;2(5):130–3.
Mansi M, Aburjai TA. Lipid profile in Jordanian children with beta thalassemia major. Int J HematolOncol. 2008;18:93–8.
Paganga G, Evans C, Rule R, et al. The interaction between ruptured erythrocytes and low density lipoproteins. FEBS. 1992;303:154. CrossRef
Al Quobaili F, Imad E. AbouAsali. Serum levels of lipid and lipoprotein in Syrian patients with B-thalssemia major. Saudi Med J. 2004;25(7):871–5. PubMed
Khubchandani A, Solanki V, Solanki M, et al. Estimation of serum lipid profiles in patients with beta thalassemia major. Int J Res Med. 2014;3(2):65–7.
Shams S, Ashtiani MT, Monajemzadeh M, Koochakzadeh L, Irani H, Jafari F, Mohseni A. Evaluation of serum insulin, glucose, lipid profile, and liver function in β-thalassemia major patients and their correlation with iron overload. Labmedicine. 2010;41(80):486–9.
Ricchi P, Ammirabile M, Spasiano A, et al. Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients. Europ J Hematol. 2009;82:219–22. CrossRef
Chrysohou C, Panagiotakos DB, Pistavos C, et al. Distribution of serum lipid and lipoprotein in patients with beta thalassemia major: an epidemiological study in young adults from Greece. Lipid Health Dis. 2004;3:3–8. CrossRef
Jacobs A. The pathology of iron overload. In: Jacobs A, Wor-wood M, editors. Iron in biochemistry and medicine II. New York: Academic; 1980. p. 427.
Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and antioxidant status in B-thalassemia major: iron overload and depletion of lipid soluble antioxidant. Blood. 1996;88:3608. PubMed
Susanti E, Donosepoetro M, Patellong I, et al. Differences between several atherogenic parameters in patients with controlled and uncontrolled type 2 Diabetes Mellitus. Med J Indones. 2010;19(2):103–8. CrossRef
Daniels LB, Laughlin G, Sarno MJ. Lp- PLA2 is an independent predictor of incident coronary heart disease in apparently healthy older population. J Am Col Cadiol. 2008;51:913–9. CrossRef
Burris Ashwood ER, Burns DE. Textbook of clinical chemistry and molecular diagnostics. 4th ed. St louis: Elseiver, Saunders; 2006.
- Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker
Laila M. Sherief
Hanan S. Sherbiny
Naglaa M. Kamal
Osama Abd Alazez
Mohamed Abd Alhady
Wesam A. Mokhtar
- BioMed Central
Neu im Fachgebiet Pädiatrie
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II